Claudia Sissi

Prof. Claudia Sissi

University of Padova, Dept. of Pharmaceutical and Pharmacological Sciences Via Marzolo, 5-35131 Padova, Italy
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Current Medicinal Chemistry - Anti-Cancer Agents
Verified
Journal Article
Closed access
PDF file
Claudia SissiClaudia Sissi
Claudia Sissi
Manlio PalumboManlio Palumbo
Manlio Palumbo
The present review focuses on the structural modifications responsible for the transformation of an antibacterial into an anticancer agent. Indeed, a distinctive feature of drugs based on the quinolone structure is their remarkable ability to target different type II topoisomerase enzymes. In particular, some congeners of this drug family display high activity not only against bacterial topoisomerases, but also against eukaryotic topoisomerases and are toxic to cultured mammalian cells and in vivo tumor models. Hence, these cytotoxic quinolones represent an exploitable source of new anticancer agents, which might also help addressing side-toxicity and resistance phenomena. Their ability to bind metal ion cofactors represents an additional means of modulating their pharmacological response(s). Moreover, quinolones link antibacterial and anticancer chemotherapy together and provide an opportunity to clarify drug mechanism across divergent species.

1 May 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
RRRiccardo Rigo
Riccardo Rigo
Manlio PalumboManlio Palumbo
Manlio Palumbo
Claudia SissiClaudia Sissi
Claudia Sissi

1 January 2014 in Metallomics
Verified
Journal Article
Open access
PDF file
OPO. Pinato
O. Pinato
CMC. Musetti
C. Musetti
Claudia SissiClaudia Sissi
Claudia Sissi
The mechanism of action of platinum-based drugs derives from different contributions of DNA and proteins.

18 February 2010 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
Claudia SissiClaudia Sissi
Claudia Sissi
Manlio PalumboManlio Palumbo
Manlio Palumbo

1 January 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Claudia SissiClaudia Sissi
Claudia Sissi
LLLorena Lucatello
Lorena Lucatello
AKA. Paul Krapcho
A. Paul Krapcho
DMDavid J. Maloney
David J. Maloney
MBMatthew B. Boxer
Matthew B. Boxer
Manlio PalumboManlio Palumbo
Manlio Palumbo

21 December 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AKAnita Kotar
Anita Kotar
RRRiccardo Rigo
Riccardo Rigo
Claudia SissiClaudia Sissi
Claudia Sissi
JPJanez Plavec
Janez Plavec
In the promoter of c-KIT proto-oncogene, whose deregulation has been implicated in many cancers, three G-rich regions (kit1, kit* and kit2) are able to fold into G-quadruplexes. While kit1 and kit2 have been studied in depth, little information is available on kit* folding behavior despite its key role in regulation of c-KIT transcription. Notably, kit* contains consensus sites for SP1 and AP2 transcription factors. Herein, a set of complementary spectroscopic and biophysical methods reveals that kit*, d[GGCGAGGAGGGGCGTGGCCGGC], adopts a chair type antiparallel G-quadruplex with two G-quartets at physiological relevant concentrations of KCl. Heterogeneous ensemble of structures is observed in the presence of Na+ and NH4+ ions, which however stabilize pre-folded structure. In the presence of K+ ions stacking interactions of adenine and thymine residues on the top G-quartet contribute to structural stability together with a G10•C18 base pair and a fold-back motif of the five residues at the 3′-terminal under the bottom G-quartet. The 3′-tail enables formation of a bimolecular pre-folded structure that drives folding of kit* into a single G-quadruplex. Intriguingly, kinetics of kit* G-quadruplex formation matches timescale of transcriptional processes and might demonstrate interplay of kinetic and thermodynamic factors for understanding regulation of c-KIT proto-oncogene expression.